1.
Chinese Journal of Clinical Pharmacology and Therapeutics
;
(12): 423-427, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-1014863
ABSTRACT
β-blockers are widely administered to patients with various cardiovascular diseases including hypertension. However, in recent years, studies have questioned or even denied the antihypertensive effect of β-blockers, which has caused confusion to cardiovascular clinicians. Based on the systematic analysis of a number of studies, the author believes that β-blockers still remain the status as the first-line antihypertensives.